The DOI matches its Crossref record; 185 of the 188 references it cites were found in a registry or an index.
Neuroprotective strategies involving ROS in Alzheimer disease
Open accessAbstract
Alzheimer disease (AD) is a neurodegenerative disorder in which oxidative stress is a key hallmark. It occurs early in disease pathogenesis and can exacerbate its progression. Several causes of oxidative stress have been determined over the years. First, mitochondria play an important role in the generation and accumulation of free radicals. In addition to mitochondria, inflammation can also induce oxidative damage, especially via microglia, and microglia are also important for Aβ clearance. In AD, both mitochondrial function and inflammatory response are affected, leading to increased ROS formation and oxidative damage to lipid, proteins, and nucleic acids. Some other sources have also been identified. From these findings, various neuroprotective strategies against ROS-mediated damages have been elaborated in AD research. This review recapitulates some of the major strategies used to prevent oxidative stress and disease progression. Outcomes from in vitro and in vivo studies using models of AD are encouraging. However, only a few clinical trials have provided positive results in terms of slowing down cognitive decline. Nonetheless, there is still hope for improved compounds that would better target pathways implicated in ROS production. In fact, facilitating the endogenous antioxidant system by modulating transcription has great promise for AD therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Oxidative stress markers increase even in the preclinical phase and during MCI, while antioxidant therapies in animal models have been shown to delay the disease course and improve cognitive functions [122, 123].”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, in advanced AD—characterized by widespread neuronal damage and complex pathological remodeling—the effectiveness of antioxidant therapy is significantly reduced. Numerous unsuccessful clinical trials have reported minimal cognitive improvements in patients at advanced disease stages [123–125].”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Scientific evidence clearly indicates that targeting ROS and oxidative stress is more effective during the early stages of AD than in advanced stages.”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In summary, ROS-targeting strategies exhibit the greatest efficacy in early AD, before irreversible neuronal damage occurs [122, 123].”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [123]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wenz, T., Diaz, F., Spiegelman, B. M., & Moraes, C. T. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.006 · Cited by 297
RetractedMitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Self-citationThe Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress
Nguyen, T., Nioi, P., & Pickett, C. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r900010200 · Cited by 2,655
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
Moi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607
Vitamin E, antioxidant and nothing more
Traber, M. G., & Atkinson, J. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.024 · Cited by 1,547
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Research works printed but not linked: 1
- 2010, Acetyl-L-carnitine, Monogr. Altern. Med. Rev., 15, 76
Cited by
Sorted by citations
Items 101–200 of 407
Alzheimer’s Disease and Antioxidant Therapy: How Long How Far?
Teixeira, J., Silva, T., Andrade, P. B., & Borges, F. (2013) · Current Medicinal Chemistry · doi:10.2174/1871523011320240001 · Cited by 59
Rezvani-Kamran, A., Salehi, I., Shahidi, ., Zarei, M., Moradkhani, S., & Komaki, A. (2017) · Pharmaceutical Biology · doi:10.1080/13880209.2017.1362010 · Cited by 59
The Antioxidant Effects of Thymoquinone in Activated BV-2 Murine Microglial Cells
Cobourne-Duval, M. K., Taka, E., Mendonca, P., Bauer, D., & Soliman, K. F. A. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2047-1 · Cited by 56
Zhang, W., Wang, X., Li, P., Xiao, H., Zhang, W., Wang, H., & Tang, B. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b01290 · Cited by 57
Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials
Drygalski, K., Fereniec, E., Koryciński, K., Chomentowski, A., Kiełczewska, A., Odrzygóźdź, C., & Modzelewska, B. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.09.019 · Cited by 57
Antioxidant therapy: Still in search of the ‘magic bullet’
Benfeito, S., Oliveira, C., Soares, P., Fernandes, C., Silva, T., Teixeira, J., & Borges, F. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.12.002 · Cited by 55
In vitro assessment of cytogenetic and oxidative effects of α-pinene
Türkez, H., & Aydın, E. (2013) · Toxicology and Industrial Health · doi:10.1177/0748233713498456 · Cited by 55
Chao, X., Chen, Z., Liu, A., He, X., Wang, S., Wang, Y., Liu, P., Ramassamy, C., Mak, S., Cui, W., et al. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12286 · Cited by 55
Prasad, S. N., & ., M. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23393 · Cited by 55
Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology
Guo, J., Cheng, J., North, B. J., & Wei, W. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.07.001 · Cited by 55
Zhang, W., Hua, H., Guo, Y., Cheng, Y., Pi, F., Yao, W., Xie, Y., & He, Q. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c01892 · Cited by 55
Chandran, G., & ., M. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.04.002 · Cited by 54
Shinomol, G. K., Bharath, M. M. S., & ., M. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9303-6 · Cited by 54
Polyphenol Antioxidants from Natural Sources and Contribution to Health Promotion
Andrade, J. M. D. M., & Fasolo, D. (2013) · Polyphenols in Human Health and Disease · doi:10.1016/b978-0-12-398456-2.00020-7 · Cited by 60
Matsumura, A., Emoto, M. C., Suzuki, S., Iwahara, N., Hisahara, S., Kawamata, J., Suzuki, H., Yamauchi, A., Sato‐Akaba, H., Fujii, H. G., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.04.013 · Cited by 52
Dietary Polyphenols and Their Effects on Cell Biochemistry and Pathophysiology 2013
Maraldi, T., Vauzour, D., & Angeloni, C. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/576363 · Cited by 55
Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment
Chico, L., Simoncini, C., Gerfo, A. L., Rocchi, A., Petrozzi, L., Carlesi, C., Volpi, L., Tognoni, G., Siciliano, G., & Bonuccelli, U. (2013) · Free Radical Research · doi:10.3109/10715762.2013.804622 · Cited by 49
Kochman, U., Sitka, H., Kuźniar, J., Czaja, M., Kozubek, P., Beszłej, J. A., & Leszek, J. (2026) · Molecular Neurobiology · doi:10.1007/s12035-025-05417-z · Cited by 60
Ma, W., Hou, C.-C., Zhou, X. J., Yu, H., Xi, Y., Ding, J., Zhao, X., & Xiao, R. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1019-y · Cited by 50
Leporini, M., Bonesi, M., Loizzo, M. R., PASSALACQUA, N. G., & Tundis, R. (2020) · Plants · doi:10.3390/plants9060798 · Cited by 50
Ramirez, A., van der Flier, W. M., Herold, C., Ramonet, D., Heilmann, S., Lewczuk, P., Popp, J., Lacour, A., Drichel, D., Louwersheimer, E., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu372 · Cited by 49
Herbst, K. J., Liu, L., James, M., Yao, Y., Xie, S. X., & Brunden, K. R. (2015) · Scientific Reports · doi:10.1038/srep18286 · Cited by 50
Key Role of Mitochondria in Alzheimer’s Disease Synaptic Dysfunction
Cavallucci, V., Ferraina, C., & D’Amelio, M. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319360005 · Cited by 47
Discover the network mechanisms underlying the connections between aging and age-related diseases
Yang, J., Huang, T., Song, W.-M., Petralia, F., Mobbs, C. V., Zhang, B., Zhao, Y., Schadt, E. E., Zhu, J., & Tu, Z. (2016) · Scientific Reports · doi:10.1038/srep32566 · Cited by 46
Rao, S. V., Hemalatha, P., Yetish, S., Muralidhara, M., & Rajini, P. S. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00451-y · Cited by 46
Two-photon fluorescence imaging of the cerebral peroxynitrite stress in Alzheimer's disease
Xie, X., Liu, Y., Liu, G., Zhao, Y., Liu, J., Li, Y., Zhang, J., Jiao, X., Wang, X., & Tang, B. (2022) · Chemical Communications · doi:10.1039/d2cc01744j · Cited by 45
Shohag, S., Akhter, S., Islam, M. S., Sarker, T., Sifat, M. K., Rahman, M. M., Islam, M. R., & Sharma, R. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7743705 · Cited by 49
Manjunath, M. J., & ., M. (2013) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524911313010007 · Cited by 45
Singh, A., & Kumar, A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00268 · Cited by 45
Abbassi, Y. A., Mohammadi, M. T., Foroshani, M. S., & Sarshoori, J. R. (2016) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2016.067 · Cited by 45
Neuroprotective effects of hydrogen sulfide on sodium azide-induced oxidative stress in PC12 cells
Gao, C. H., Chang, P., Yang, L., Wang, Y. H., Zhu, S., Shan, H., Zhang, M., & Tao, L. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3227 · Cited by 45
Özkan, E. E., Yilmaz‐Ozden, T., Özsoy, N., & Mat, A. (2017) · South African Journal of Botany · doi:10.1016/j.sajb.2017.10.022 · Cited by 45
Kosmopoulou, D., Lafara, M.-P., Adamantidi, T., Ofrydopoulou, A., Grabrucker, A. M., & Τσούπρας, Α. (2024) · Applied Sciences · doi:10.3390/app14156417 · Cited by 45
Inestrosa, N. C., Ríos, J. A., Cisternas, P., Tapia‐Rojas, C., Rivera, D. S., Braidy, N., Zolezzi, J. M., Godoy, J. A., Carvajal, F. J., Ardiles, Á. O., et al. (2014) · Brain Pathology · doi:10.1111/bpa.12226 · Cited by 47
Antiinflammatory Potential of Medicinal Plants: A Source for Therapeutic Secondary Metabolites
Bernstein, N., Akram, M., Daniyal, M., Koltai, H., Fridlender, M., & Gorelick, J. (2018) · Advances in agronomy · doi:10.1016/bs.agron.2018.02.003 · Cited by 51
Liao, L., Shi, J., Jiang, C., Zhang, L., Feng, L., Liu, J., & Zhang, J. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.01.026 · Cited by 45
Benfeito, S., Oliveira, C., Fernandes, C., Cagide, F., Teixeira, J., Amorim, R., Garrido, J. M. P. J., Martins, C., Sarmento, B. F. C. C., Silva, R. V. D. S., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.055 · Cited by 48
Chiang, M., Nicol, C. J. B., Lin, C., Chen, S., Yen, C., & Huang, R. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104992 · Cited by 44
The vascular side of Alzheimer's disease
Liesz, A. (2019) · Science · doi:10.1126/science.aay2720 · Cited by 48
Hriţcu, L., Bağcı, E., Akbaba, E., & Mihăşan, M. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1662-6 · Cited by 42
Bae, S., LEE, E.-J., Lee, J. H., Park, I., Lee, S., Hahn, H. J., Ahn, K. J., An, S., An, I., & Cha, H. J. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1561 · Cited by 47
Cisternas, P., Lindsay, C. B., Salazar, P. L., Silva-Álvarez, C., Retamales-Ortega, R., Serrano, F. G., Vio, C. P., & Inestrosa, N. C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.09.009 · Cited by 42
Plant-derived mitochondria-targeting cysteine-rich peptide modulates cellular bioenergetics
Kam, A., Loo, S., Dutta, B., Sze, S. K., & Tam, J. P. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006693 · Cited by 40
Vitamin E, Turmeric and Saffron in Treatment of Alzheimer’s Disease
Adalier, N., & Parker, H. (2016) · Antioxidants · doi:10.3390/antiox5040040 · Cited by 40
Sun, Z., Liu, K., Liang, C., Wen, L., Wu, J., Liu, X., & Li, X. (2024) · Phytotherapy Research · doi:10.1002/ptr.8214 · Cited by 43
Prinz, M., Parlar, S., Bayraktar, G., Alptüzün, V., Erciyas, E., Fallarero, A., Karlsson, D., Vuorela, P. M., Burek, M., Förster, C. Y., et al. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.04.024 · Cited by 40
Tian, X., Guo, L.-P., Hu, X., Huang, J., Fan, Y., Ren, T., & Zhao, Q. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0129-7 · Cited by 39
Kiametis, A. S., Silva, M. A., Romeiro, L. A. S., Martins, J. B. L., & Gargano, R. (2017) · Journal of Molecular Modeling · doi:10.1007/s00894-017-3228-9 · Cited by 40
Choi, J., Kwon, H., Lee, J., Lee, Y., Seoh, J., & Han, P. (2019) · Aging Cell · doi:10.1111/acel.12888 · Cited by 39
Redox Processes in Neurodegenerative Disease Involving Reactive Oxygen Species
Kovacic, P., & Somanathan, R. (2012) · Current Neuropharmacology · doi:10.2174/157015912804143487 · Cited by 38
Bağcı, E., Akbaba, E., Mihăşan, M., Maniu, C. L., & Hriţcu, L. (2015) · Flavour and Fragrance Journal · doi:10.1002/ffj.3289 · Cited by 40
Hwang, C. J., Yun, H., Jung, Y. Y., Lee, D. H., Yoon, N. Y., Seo, H. O., Han, J., Oh, K., Choi, D. Y., Han, S., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8739-0 · Cited by 37
Li, R., Yang, Q., Qiu, X., Li, K., Li, G., Zhu, P., & Zhu, T. (2013) · Environmental Science & Technology · doi:10.1021/es400027v · Cited by 37
Wang, M., Zhang, X., Liu, H., Ma, W., Zhang, M., Zhang, Y., Li, X., Dou, M., Jing, Y., Chu, Y., et al. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.08.006 · Cited by 37
Chandran, G., & ., M. (2013) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-013-9959-y · Cited by 37
Transdermal delivery of dimethyl fumarate for Alzheimer’s disease: Effect of penetration enhancers
Ameen, D. W., & Michniak‐Kohn, B. B. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.031 · Cited by 37
Targeted Antioxidant, Catalase–SKL, Reduces Beta‐Amyloid Toxicity in the Rat Brain
Nell, H. J., Au, J. L., Giordano, C. R., Terlecky, S. R., Walton, P. A., Whitehead, S. N., & Cechetto, D. F. (2016) · Brain Pathology · doi:10.1111/bpa.12368 · Cited by 36
Benzimidazole-derived Compounds Designed for Different Targets of Alzheimer’s Disease
Gülcan, H. O., Mavideniz, A., Sahin, M. F., & Orhan, İ. E. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190124123208 · Cited by 35
Irge, D. D., Cheng, L., Manzoor, M., Liu, Q., Wang, Y., Xiang, L., & Qi, J. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3184019 · Cited by 35
Cavaleri, F. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.10.009 · Cited by 36
Owona, B. A., Njayou, N. F., Laufer, S., Moundipa, P. F., & Schluesener, H. J. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.06.016 · Cited by 35
Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer’s Disease
Cacciatore, I., Marinelli, L., Fornasari, E., Cerasa, L. S., Eusepi, P., Türkez, H., Pomilio, C., Reale, M., D’Angelo, C., Costantini, E., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071035 · Cited by 35
Li, Y., Zhu, X., Wang, K., Zhu, L., Murray, M. T., & Zhou, F. (2022) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgac036 · Cited by 37
Wilson, A. A., Sadovski, O., Nóbrega, J. N., Raymond, R., Bambico, F. R., Nashed, M. G., García, A., Bloomfield, P. M., Houle, S., Mizrahi, R., et al. (2017) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2017.05.011 · Cited by 35
Kupershmidt, L., & Youdim, M. B. H. (2023) · Cells · doi:10.3390/cells12050763 · Cited by 36
Wang, C., He, L., Yan, M., Zheng, G., & Liu, X. (2014) · AGE · doi:10.1007/s11357-014-9676-6 · Cited by 33
Insulin prevents mitochondrial generation of H2O2 in rat brain
Muller, A. P., Haas, C. B., Camacho-Pereira, J., Brochier, A., Gnoatto, J. A., Zimmer, E. R., Souza, D. O., Galina, A., & Portela, L. V. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.03.007 · Cited by 35
Ogunsuyi, O. B., Olagoke, O. C., Afolabi, B. A., Oboh, G., Ijomone, O. M., Barbosa, N. V., & da Rocha, J. B. T. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2021.1933331 · Cited by 33
Benzimidazole as a Privileged Scaffold in Drug Design and Discovery
Kumar, R., Marianesan, A. B., & Pathak, S. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266314704240522112439 · Cited by 32
Miao, H. H., Zhang, Y., Ding, G.-N., Hong, F. X., Dong, P., & Tian, M. (2017) · PubMed · doi:10.3967/bes2017.047 · Cited by 32
Sagnou, M., Mavroidi, B., Shegani, A., Paravatou‐Petsotas, M., Raptopoulou, C. P., Psycharis, V., Pirmettis, I. C., Papadopoulos, M. S., & Pelecanou, M. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01949 · Cited by 32
Wang, Y., Xiong, B., Lin, H., Li, Q., Yang, H., Qiao, Y., Li, Q., Xu, Z., Lyu, W., Qu, W., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114806 · Cited by 32
Shinomol, G. K., Bharath, M. M. S., & ., M. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-030 · Cited by 32
Chen, C. T., Trépanier, M., Hopperton, K. E., Domenichiello, A. F., Masoodi, M., & Bazinet, R. P. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.221 · Cited by 31
Clarke, K., Ricciardi, S., Pearson, T., Bharudin, I., Davidsen, P. K., Bonomo, M., Brina, D., Scagliola, A., Simpson, D. M., Beynon, R. J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.040 · Cited by 29
Tian, X., Gao, L., Li, A., Jiang, X., Bai, J.-P., Huang, J. M., Meng, W., & Zhao, Q. (2016) · Neurological Research · doi:10.1080/01616412.2016.1245030 · Cited by 31
Wang, C., Liao, Y., Wang, S., Wang, D., Wu, N., Xu, Q., Jiang, W., Qiu, M., & Liu, C. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8750 · Cited by 30
Ano, Y., Kutsukake, T., Hoshi, A., Yoshida, A., & Nakayama, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116598 · Cited by 29
Lai, A. Y., & McLaurin, J. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14130 · Cited by 31
Rawat, K., Tewari, D., Bisht, A., Chandra, S., Tiruneh, Y. K., Hassan, H. M., Al‐Emam, A., Sindi, E. R., & Al-Dies, A.-A. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-81285-2 · Cited by 35
Bioenergetic failure and oxidative stress: mitochondrial contributions to Alzheimer’s disease
Wasim, R. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01916-6 · Cited by 31
Conte‐Daban, A., Boff, B., Matias, A. C., Aparicio, C. N. M., Gateau, C., Lebrun, C., Cerchiaro, G., Kieffer, I., Sayen, S., Guillon, E., et al. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201703429 · Cited by 29
Global cPILOT analysis of the APP/PS‐1 mouse liver proteome
Evans, A. R., Gu, L., Guerrero, R., & Robinson, R. A. S. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201400149 · Cited by 26
Association of Anterior Cingulate Glutathione with Sleep Apnea in Older Adults At-Risk for Dementia
Duffy, S. L., Lagopoulos, J., Terpening, Z., Lewis, S. J. G., Grunstein, R. R., Mowszowski, L., Cross, N. E., Hermens, D. F., Hickie, I. B., & Naismith, S. L. (2016) · SLEEP · doi:10.5665/sleep.5650 · Cited by 28
Guillén, P. O., Gegunde, S., Jaramillo, K. B., Alfonso, A., Calabro, K., Alonso, E., Rodríguez, J. A., Botana, L. M., & Thomas, O. (2018) · Marine Drugs · doi:10.3390/md16070242 · Cited by 28
Duangjan, C., Rangsinth, P., Zhang, S., Gu, X., Wink, M., & Tencomnao, T. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.634100 · Cited by 28
TDP-43: A new player on the AD field?
Youmans, K. L., & Wolozin, B. L. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.05.018 · Cited by 28
Kam, M. K., Lee, D. G., Kim, B., Lee, H., Lee, S., Bae, Y. C., & Lee, D. (2019) · Cell Biology and Toxicology · doi:10.1007/s10565-019-09477-5 · Cited by 29
Recent progress in organelle-targeting fluorescent probes for the detection of peroxynitrite
Li, L., Wang, C., Hu, J., & Chen, W. (2024) · Chemical Communications · doi:10.1039/d4cc03452j · Cited by 27
Ferro, D., Franchi, N., Bakiu, R., Ballarin, L., & Santovito, G. (2017) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2017.12.002 · Cited by 27
Krishnan, N., Vairamani, M., Dhanabalan, A. K., Velmurugan, D., Gopinath, S. C. B., & Pachaiappan, R. (2022) · Biomass Conversion and Biorefinery · doi:10.1007/s13399-022-03237-y · Cited by 27
Juvekar, A. R., & Khatri, D. K. (2016) · International journal of Nutrition Pharmacology Neurological Diseases · doi:10.4103/2231-0738.179969 · Cited by 27
Nesi, G., Chen, Q., Sestito, S., Digiacomo, M., Yang, X., Wang, S., Pi, R., & Rapposelli, S. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.006 · Cited by 27
Exploring Alzheimer's disease treatment: Established therapies and novel strategies for future care
Soni, U., Singh, K., Jain, D., & Pujari, R. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177520 · Cited by 28
Effects of Eugenol on Alzheimer’s Disease-like Manifestations in Insulin- and Aβ-Induced Rat Models
Taheri, P., Yaghmaei, P., Tehrani, H. S., & Ebrahim‐Habibi, A. (2019) · Neurophysiology · doi:10.1007/s11062-019-09801-z · Cited by 26
Lin, L., Li, C., Li, T., Zheng, J., Shu, Y., Zhang, J., Shen, Y., & Ren, D. (2023) · Food Frontiers · doi:10.1002/fft2.210 · Cited by 28
Türkez, H., Aydın, E., Geyikoğlu, F., & Çetin, D. (2014) · Cytotechnology · doi:10.1007/s10616-014-9698-z · Cited by 26
Bahna, S. G., Sathiyapalan, A., Foster, J. A., & Niles, L. P. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.05.056 · Cited by 27
Brose, R. D., Lehrmann, E., Zhang, Y., Reeves, R. H., Smith, K. D., & Mattson, M. P. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.08.021 · Cited by 26
Metadata
- Authors
- Dumont, M., & Beal, M. F.
- Affiliations
- Weill Cornell Medicine (US)
- Corresponding author
- Dumont, Magali
- Venue
- Free Radical Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 51
- Issue
- 5
- Pages
- 1014-1026
- ISSN
- 0891-5849 (ISSN-L)
- PMC
- PMC3070183
- OpenAlex
- W2080084871
- Cited by
- 402
- References
- 188
- Citations by year
- 2026: 12 · 2025: 19 · 2024: 21 · 2023: 20 · 2022: 21 · 2021: 22 · 2020: 26 · 2019: 28 · 2018: 19 · 2017: 36 · 2016: 28 · 2015: 29 · 2014: 36 · 2013: 34 · 2012: 34
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Free Radical Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG20729, R01AG020729, P01AG014930, P01-AG14930)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- Alzheimer's disease, reactive oxygen species, oxidative stress, neuroprotection, mitochondria, microglia, neuroinflammation, amyloid-beta clearance, antioxidant defense, transcriptional regulation, neurodegeneration, cognitive decline
- MeSH terms
- Alzheimer Disease, Animals, Antioxidants, Clinical Trials as Topic, Disease Models, Animal, Humans, Inflammation, Mitochondria, Oxidation-Reduction, Reactive Oxygen Species, Microglia, Oxidative Stress, Disease Progression, Neuroprotective Agents, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review